Transcriptional control of chondrocyte fate and differentiation

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 75, Issue 3, 2005, Pages 200-212

  Lefebvre, Véronique ^a   Smits, Patrick ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; TRANSCRIPTION FACTOR NKX3.1; TRANSCRIPTION FACTOR NKX3.2; TRANSCRIPTION FACTOR PAX1; TRANSCRIPTION FACTOR PAX9; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

BODY GROWTH; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CHONDRODYSOSTOSIS; CHONDRODYSPLASIA; CHONDROGENESIS; EMBRYO PATTERN FORMATION; EXPECTANCY; GROWTH PLATE; MESENCHYME; NONHUMAN; OSSIFICATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SKELETON MALFORMATION; TRANSCRIPTION REGULATION; VERTEBRATE;

ANIMALS; CARTILAGE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHONDROCYTES; CHONDROGENESIS; DOWN-REGULATION; HUMANS; MESODERM; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

VERTEBRATA;

EID: 26844502418     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20048     Document Type: Review

References (82)

1. Abad V, Meyers JL, Weise M, et al. 2002. The role of the resting zone in growth plate chondrogenesis. Endocrinology 143:1851-1857.
2. Adams CS, Shapiro IM. 2002. The fate of the terminally differentiated chondrocyte: evidence for microenvironmental regulation of chondrocyte apoptosis. Crit Rev Oral Biol Med 13: 465-473.
3. Akiyama H, Chaboissier MC, Martin JF, et al. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-2828.
4. Akiyama H, Lyons JP, Mori-Akiyama Y, et al. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087.
5. Archer CW, Dowthwaite GP, Francis-West P. 2003. Development of synovial joints. Birth Defects Res C Embryo Today 69: 144-155.
6. Bell DM, Leung KK, Wheatley SC, et al. 1997. SOX9 directly regulates the type-II collagen gene. Nat Genet 16: 174-178.
7. Bi W, Deng JM, Zhang Z, et al. 1999. Sox9 is required for cartilage formation. Nat Genet 22:85-89.
8. Brent AE, Braun T, Tabin CJ. 2005. Genetic analysis of interactions between the somitic muscle, cartilage and tendon cell lineages during mouse development. Development 132:515-528.
9. Bridgewater LC, Lefebvre V, de Crombrugghe B. 1998. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273:14998-15006.
10. Cohn DH. 2001. Defects in extracellular matrix structural proteins in the osteochondrodysplasias. Novartis Found Symp 232:195-212.
11. Davies SR, Sakano S, Zhu Y, Sandell LJ. 2002. Distribution of the transcription factors Sox9, AP-2, and δEF1 in adult murine articular and meniscal cartilage and growth plate. J Histochem Cytochem 50:1059-1065.
12. DeLise AM, Fischer L, Tuan RS. 2000. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 8:309-334.
13. Deutsch U, Dressler GR, Gruss P. 1988. Pax 1, a member of a paired box homologous murine gene family, is expressed in segmented structures during development. Cell 53:617-625.
14. Ducy P, Zhang R, Geoffroy V, et al. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
15. Ferrari D, Kosher RA. 2002. Dlx5 is a positive regulator of chondrocyte differentiation during endochondral ossification. Dev Biol 252:257-270.
16. Foster JW, Dominguez-Steglich MA, Guioli S, et al. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
17. Girkontaite I, Frischholz S, Lammi P, et al. 1996. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 15:231-238.
18. Hall BK, Miyake T. 2000. All for one and one for all: condensations and the initiation of skeletal development. Bioessays 22:138-147.
19. Herbrand H, Pabst O, Hill R, Arnold HH. 2002. Transcription factors Nkx3.1 and Nkx3.2 (Bapx1) play an overlapping role in sclerotomal development of the mouse. Mech Dev 117:217-224.
20. Hess J, Porte D, Munz C, Angel P. 2001. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem 276:20029-20038.
21. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B. 2001. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci U S A 98:160-165.
22. Ikeda T, Kamekura S, Mabuchi A, et al. 2004. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50:3561-3573.
23. Inada M, Yasui T, Nomura S, et al. 1999. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214:279-290.
24. Iwamoto M, Higuchi Y, Koyama E, et al. 2000. Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. J Cell Biol 150:27-40.
25. Iwamoto M, Kitagaki J, Tamamura Y, et al. 2003. Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone-related peptide (PTHrP). Osteoarthritis Cartilage 11:6-15.
26. Iwamoto M, Koyama E, Enomoto-Iwamoto M, Pacifici M. 2005. The balancing act of transcription factors C-1-1 and Runx2 in articular cartilage development. Biochem Biophys Res Commun 328:777-782.
27. Kerppola TK, Curran T. 1994. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. Oncogene 9:675-684.
28. Kim IS, Otto F, Zabel B, Mundlos S. 1999. Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 80:159-170.
29. Kirn-Safran CB, Gomes RR, Brown AJ, Carson DD. 2004. Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today 72: 69-88.
30. Kobayashi T, Soegiarto DW, Yang Y, et al. 2005. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 115:1734-1742.
31. Komori T, Yagi H, Nomura S, et al. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
32. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-336.
33. Kuboki T, Kanyama M, Nakanishi T, et al. 2003. Cbfa1/Runx2 gene expression in articular chondrocytes of the mice temporomandibular and knee joints in vivo. Arch Oral Biol 48:519-525.
34. Kundu M, Javed A, Jeon JP, et al. 2002. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 32:639-644.
35. Lefebvre V, Huang W, Harley VR, et al. 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro-alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346.
36. Lefebvre V, Li P, de Crombrugghe B. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-5733.
37. Lefebvre V. 2002. Toward understanding the functions of the two highly related Sox5 and Sox6 genes. J Bone Miner Metab 20:121-130.
38. Lettice LA, Purdie LA, Carlson GJ, et al. 1999. The mouse bagpipe gene controls development of axial skeleton, skull, and spleen. Proc Natl Acad Sci USA 96:9695-9700.
39. Li TF, Dong Y, Ionescu AM, et al. 2004. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. Exp Cell Res 299:128-136.
40. Liu Y, Li H, Tanaka K, et al. 2000. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J Biol Chem 275:12712-12718.
41. MacLean HE, Kim JI, Glimcher MJ, et al. 2003. Absence of transcription factor c-maf causes abnormal terminal differentiation of hypertrophic chondrocytes during endochondral bone development. Dev Biol 262:51-63.
42. Magee C, Nurminskaya M, Faverman L, et al. 2005. SP3/SP1 transcription activity regulates specific expression of collagen type X in hypertrophic chondrocytes. J Biol Chem 280:25331-25338.
43. Meech R, Edelman DB, Jones FS, Makarenkova HP. 2005. The homeobox transcription factor Barx2 regulates chondrogenesis during limb development. Development 132:2135-2146.
44. Mori-Akiyama Y, Akiyama H, Rowitch DH, de Crombrugghe B. 2003. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci USA 100:9360-9365.
45. Mundlos S, Olsen BR. 1997a. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11:125-132
46. Mundlos S, Olsen BR. 1997b. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J 11:227-233.
47. Mundlos S, Otto F, Mundlos C, et al. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779.
48. Ng LJ, Wheatley S, Muscat GE, et al. 1997. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183:108-121.
49. Olsen BR, Reginato AM, Wang W. 2000. Bone development. Annu Rev Cell Dev Biol 16:191-220.
50. Otto F, Thornell AP, Crompton T, et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
51. Peters H, Neubuser A, Kratochwil K, Balling R. 1998. Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev 12:2735-2747.
52. Peters H, Wilm B, Sakai N, et al. 1999. Pax1 and Pax9 synergistically regulate vertebral column development. Development 126:5399-5408.
53. Reimold AM, Grusby MJ, Kosaras B, et al. 1996. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature 379:262-265.
54. Rentsendorj O, Nagy A, Sinko I, et al. 2005. Highly conserved proximal promoter element harboring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene. Biochem J 389:705-716.
55. Rhee DK, Marcelino J, Baker M, et al. 2005. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 115:622-631.
56. Robledo RF, Rajan L, Li X, Lufkin T. 2002. The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev 16:1089-1101.
57. Roca H, Phimphilai M, Gopalakrishnan R, et al. 2005. Cooperative interactions between RUNX2 and homeodomain protein binding sites are critical for the osteoblast-specific expression of the bone sialoprotein gene. J Biol Chem 280:30845-30855.
58. Rodrigo I, Hill RE, Balling R, et al. 2003. Pax1 and Pax9 activate Bapx1 to induce chondrogenic differentiation in the sclerotome. Development 130:473-482.
59. Sandell LJ. 1994. In situ expression of collagen and proteoglycan genes in notochord and during skeletal development and growth. Microsc Res Technol 28:470-482.
60. Sato M, Morii E, Komori T, et al. 1998. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 17:1517-1525.
61. Sekiya I, Tsuji K, Koopman P, et al. 2000. Sox 9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol Chem 275: 10738-10744.
62. Seki K, Fujimori T, Savagner P, et al. 2003. Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan. J Biol Chem 278:41862-41870.
63. Smits P, Li P, Mandel J, et al. 2001. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-290.
64. Smits P, Dy P, Mitra S, Lefebvre V. 2004. Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol 164: 747-758.
65. So CL, Kaluarachchi K, Tam PP, Cheah KS. 2001. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. Osteoarthritis Cartilage 9 Suppl A:S160-S173.
66. St-Jacques B, Hammerschmidt M, McMahon AP. 1999. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13:2072-2086.
67. Takeda S, Bonnamy JP, Owen MJ, et al. 2001. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 15:467-481.
68. Tanaka K, Tsumaki N, Kozak CA, et al. 2002. A Kruppel-associated box-zinc finger protein, NT2, represses cell-type-specific promoter activity of the alpha 2(XI) collagen gene. Mol Cell Biol 22: 4256-4267.
69. Tribioli C, Frasch M, Lufkin T. 1997. Bapx1: an evolutionary conserved homologue of the Drosophila bagpipe homeobox gene is expressed in splanchnic mesoderm and the embryonic skeleton. Mech Dev 65:145-162.
70. Tribioli C, Lufkin T. 1999. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126:5699-5711.
71. Ueta C, Iwamoto M, Kanatani N, et al. 2001. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol 153:87-100.
72. Vega RB, Matsuda K, Oh J, et al. 2004. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119:555-566.
73. Wagner T, Wirth J, Meyer J, et al. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120.
74. Wallin J, Wilting J, Koseki H, et al. 1994. The role of Pax-1 in axial skeleton development. Development 120:1109-1121.
75. Wang X, Manner RA, Horner A, et al. 2004. Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage 12:963-973.
76. Wright E, Margrave MR, Christiansen, et al. 1995. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 9:15-20.
77. Xie WF, Zhang X, Sakano S, et al. 1999. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 14: 757-763.
78. Yoshida CA, Furuichi T, Fujita T, et al. 2002. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32: 633-638.
79. Yoshida CA, Yamamoto H, Fujita T, et al. 2004. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 18:952-963.
80. Zeng L, Kempf H, Murtaugh LC, et al. 2002. Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev 16:1990-2005.
81. Zhao Q, Eberspaecher H, Lefebvre V, de Crombrugghe B. 1997. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209: 377-386.
82. Zheng Q, Zhou G, Morello R, et al. 2003. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 162:833-842.